This trial is active, not recruiting.

Condition childhood cancer
Treatments interview, clinic visit and interview, interviews and clinic visit
Sponsor Vanderbilt University
Start date August 2010
End date June 2013
Trial size 160 participants
Trial identifier NCT01223872, VICCREACH1038


This two-part research study will compare childhood cancer survivors receiving specialized follow-up care in the REACH for Survivorship clinic to patients receiving routine follow-up care.

United States No locations recruiting
Other countries No locations recruiting

Study Design

Observational model cohort
Standard Interview (2-15 years from last treatment) Demographic data interview (pre-initial study interview)
clinic visit and interview
REACH Clinic Visit(initial or regular) Post-REACH Clinic Interview (3mos from initial or regular clinic visit) Demographic data interview(pre-initial study interview)
interviews and clinic visit
Pre-REACH Clinic Interview(2-15 yrs from last treatment) REACH Clinic Visit(initial or regular) Post-REACH Clinic Interview(1mo from initial clinic visit) Post-REACH Clinic Interview(3mos from initial or regular clinic visit) Demographic data interview(pre-initial study interview)

Primary Outcomes

Knowledge gained by attending a multispecialty Survivorship Clinic which will be measured by comparison of self report with medical record data in both cross-sectional and longitudinal approach.
time frame: 12 months

Secondary Outcomes

Characterizing how the initial consultation in a specialized clinic impacts childhood cancer survivors' knowledge of their cancer diagnosis, treatment, and risk of late effects by comparing patient's understanding among 3 sampled timepoints.
time frame: pre-clinic and a post-clinic interviews at 1 and 3 months.
An analysis of differences in relative levels of recommended screening for late effects that childhood cancer survivors have received based on the type of their long-term follow-up care comparing medical records against Survivorship Care Plan.
time frame: 12 months
A qualitative evaluation of program feedback will serve to improve the care provided in the REACH for Survivorship clinic
time frame: 12 months

Eligibility Criteria

Male or female participants up to 21 years old.

Inclusion Criteria: - Treatment for primary malignancy per risk-adapted protocol - Age ≤ 21 years at time of diagnosis - Currently alive without evidence of disease - Off therapy for no more than 15 years Exclusion Criteria: -Patients who have received a bone marrow transplant

Additional Information

Official title Childhood Cancer Survivors' Knowledge of Their Diagnosis, Treatment, and Risk of Late Effects: The Impact of Care in a Specialized Survivorship Clinic
Trial information was received from ClinicalTrials.gov and was last updated in June 2013.
Information provided to ClinicalTrials.gov by Vanderbilt University.